Proposed Agenda & Faculty, 3-4 November 2023
08:00am
Registration Opens
08:50am
Welcome and Introduction, Ryan Fitzpatrick, Joana Torres & Millie Long
Session I: Optimizing Biologic Therapies in IBD
Moderator: Millie Long & Paula Ministro
09:00am
Anti-TNF therapy in IBD (including biosimilars)
Joana Torres, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
09:25am
Anti-integrin therapy in IBD
Paula Ministro, Tondela-Viseu Hospital Center, Viseu, Portugall
09:50am
IL-23 therapies in IBD
Triana Lobaton, Ghent University Hospital, Ghent, Belgium
10:15am
Panel Discussion
10:45am
Coffee Break
Session II: Focus on small molecules in IBD
Moderator: Joana Torres
11:05am
Conventional immunomodulator therapy in IBD – still a role in the armamentarium?
Naila Arebi, St. Mark’s Hospital, Harrow, Middlesex, UK
11:40am
JAK Inhibitors in IBD: Does selectivity matter?
Séverine Vermeire, Leuven, Belgium
12:05pm
S1P Inhibitors in IBD – how do they work and how to use them?
Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
12:30pm
Panel Discussion
13:00pm
Independent Expert Discussion supported by Pfizer
Session III: Women’s health in IBD
Moderator: Séverine Vermeire
14:00pm
Contraceptive and Pre-Conception Counseling in IBD: the role of the Gastroenterologist
Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
14:25pm
Pregnancy and IBD
Mette Julsgaard, Aarhus University Hospital, Aarhus, Denmark
14:50pm
Post Delivery: Implications for Mum and Baby
Sophie Restellini, Hôpital de La Tour, Switzerland
15:15pm
Panel Discussion
15:45pm
Coffee Break
Session IV: Medical and surgical management of IBD
Moderators: Millie Long & Joana Torres
16:05pm
Non-invasive monitoring of IBD
Federica Furfaro, IRCCS San Raffaele Hospital
16:30pm
Treat to Target in IBD – too much or too little?
Ana Guttierrez, Hospital General Universitario de Alicante
16:55pm
Surgical Management of the female IBD patient
Susana Ourô, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
17:20pm
Panel discussion & Take-home points from day 1, Millie Long & Joana Torres
17:50pm
Adjourn
Session V: Lifespan of IBD
Moderator: Marla Dubinsky
9:00am
Successful Mentorship: A Guide for Mentees and Mentors,
Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
9:25am
A Pathway to Leadership for Women in GI: Lessons Learned
Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
9:50am
Recognition of a Global Leader in IBD
Séverine Vermeire, Leuven, Belgium
10:15am
Panel Discussion
10:45am
Coffee Break
Session VI: Positioning of Therapies in IBD
Moderator: Joana Torres
11:05am
Disease location and Severity: Considerations for Positioning of Therapies
Charlotte Hedin, Karolinska University Hospital in Stockholm, Sweden
11:35am
Safety Considerations for Positioning of Therapies
Millie Long, University of North Carolina,Chapel Hill, North Carolina, USA
11:55am
Management of Pouchitis in 2023: From Antibiotics to Biologics,
Millie Long University of North Carolina,Chapel Hill, North Carolina, USA
12:20pm
Panel Discussion
12:50pm
Independent Expert Discussion supported by Celltrion
Session VII: Lifespan of IBD
Moderators: Marla C. Dubinsky
13:50pm
Considerations for the Management of Pediatric IBD
Lissy de Ridder, The Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
14:15pm
Sexuality in the IBD patient
Joana Roseira, Centro Hospitalar do Algarve, Portugal
14:40pm
Considerations for Management of IBD in Older Individuals
Daniela Pugliese, CEMAD - IBD UNIT Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy